eStoreRx™
Online Supplement Dispensary
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
This inclusive membership contains all of the the tools you need to grow your business, including WholeLifeRx™, Nimativ®, WholeLifeQ™, eStoreRx™ and Practice Success Programs.
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
November 14 2024
Exciting research is being done in the burgeoning field called Metabolic Psychiatry, which is dedicated to addressing the bioenergetic underpinnings o...
Scientists have shown for the first time that a compound found only in avocados may inhibit processes in the pancreas that usually lead to diabetes and obesity.
We have already known for some time that diet-induced obesity (DIO) is an important risk factor for the onset of metabolic complications like insulin resistance, type 2 diabetes (T2D) and cardiovascular diseases. However, the mechanism(s) by which lipotoxicity, or elevated free fatty acids, causes metabolic dysfunction continues to be widely debated.
In this study, mice were given high-fat diets for 8 weeks to induce a state of lipotoxicity and diet-induced obesity. Then half of the rats were given avocatin B (AvoB), an avocado-derived fatty acid oxidation (FAO) inhibitor, orally, for 5 weeks. This supplement was chosen in place of avocados because the levels of AvoB in avocado varies widely.
The treated mice weighed significantly less than those in the control group at the end of the 5 weeks. They also had improved glucose intolerance, glucose utilization, and insulin sensitivity, showing that they were able to absorb and burn glucose more readily and improve their cell’s response to insulin.
Next, the scientists performed a human clinical study. They gave AvoB as a dietary supplement to participants who ate a typical western diet. It was absorbed safely without affecting their kidneys, livers or muscles. They also lost weight, although the results weren’t statistically significant.
The next step for the researchers is to test AvoB’s effects in treating people with metabolic ailments.
Related Biotics Research Products:
Submit this form and you'll receive our latest news and updates.
JAMA Network Open recently published an analysis of several large cohorts of men and women, indicating a lower risk for ...
Learn moreGynecological Endocrinology recently published a systemic review and meta-analysis examining the relationship that glyce...
Learn moreResults of a large population-based observational cohort study examining the association between weight loss and diabete...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment